Wish to keep on high of the science and politics driving biotech right this moment? Enroll to get our biotech e-newsletter in your inbox.
Coronary heart illness prevention is shifting earlier in life, with new cardiology pointers urging ldl cholesterol screening and remedy beginning as younger as 30.
In the meantime, two extra drugmakers are becoming a member of TrumpRx, ALS advocates warn funding cuts might sluggish analysis, and gadget makers are nonetheless ready years for Medicare protection after FDA approval.
This text is unique to STAT+ subscribers
Unlock this text — plus in-depth evaluation, newsletters, premium occasions, and information alerts.
Have already got an account? Log in
View All Plans